About Nephron Pharmaceuticals
Nephron Pharmaceuticals is a company based in Florida (United States) founded in 1937. Nephron Pharmaceuticals has raised $625 million across 5 funding rounds from investors including PNC, Blackrockbkcc and WhiteHawk Capital Partners. Nephron Pharmaceuticals offers products and services including Inhalation Products, 503B Outsourcing, and Contract Manufacturing.
- Headquarter Florida, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nephron Pharmaceuticals Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$625 M (USD)
in 5 rounds
-
Latest Funding Round
Not available
-
Investors
PNC
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nephron Pharmaceuticals
Nephron Pharmaceuticals offers a comprehensive portfolio of products and services, including Inhalation Products, 503B Outsourcing, and Contract Manufacturing.
Develops and manufactures solutions for respiratory ailments like asthma and COPD.
Provides sterile pre-filled medications to address shortages in hospitals.
Offers sterile medication production for medical facilities across America.
Funding Insights of Nephron Pharmaceuticals
Nephron Pharmaceuticals has successfully raised a total of $625M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nephron Pharmaceuticals
Nephron Pharmaceuticals has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include PNC, Blackrockbkcc and WhiteHawk Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage technology investments are made by TCP Venture Capital.
|
Locked | Locked | Locked | |
|
Provides asset-based financing solutions to middle market private and public companies.
|
Locked | Locked | Locked | |
|
Blackrockbkcc is maintained as a web-based entity.
|
Locked | Locked | Locked |
Investor details for Nephron Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nephron Pharmaceuticals
Investment portfolio details for Nephron Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nephron Pharmaceuticals
Detailed financials for Nephron Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nephron Pharmaceuticals Comparisons
Peer comparison for Nephron Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nephron Pharmaceuticals
Detailed competitors of Nephron Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nephron Pharmaceuticals
Complete news archive for Nephron Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nephron Pharmaceuticals
Nephron Pharmaceuticals was founded in 1937 and raised its 1st funding round 77 years after it was founded.
Nephron Pharmaceuticals is headquartered in Florida, United States. It is registered at Florida, Puerto Rico, United States.
Nephron Pharmaceuticals is a funded company, having raised a total of $625M across 5 funding rounds to date.
Nephron Pharmaceuticals was founded in 1937 and operates in the pharmaceutical sector, focusing on sterile products. Generic respiratory medications are produced, along with pre-filled sterile options to address drug shortages. Contract manufacturing and 503B outsourcing services are offered, covering development, production, and packaging in facilities located in Florida and Puerto Rico. Community initiatives and educational programs in pharmacy and healthcare are supported.
Nephron Pharmaceuticals offers Inhalation Products, 503B Outsourcing, and Contract Manufacturing.
Nephron Pharmaceuticals has 4 investors. Key investors include PNC, Blackrockbkcc, WhiteHawk Capital Partners, and TCP Venture Capital.